1. Home
  2. Stock quotes
  3. Neoleukin Therapeutics
  4. Financial Statements
  5. Income Statement
  6. Operating Expenses
Neoleukin Therapeutics logo
Neoleukin Therapeutics NLTX
$ 3.49 0.0%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-18-2024

report update icon

Neoleukin Therapeutics Operating Expenses 2011-2024 | NLTX

Annual Operating Expenses Neoleukin Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
55.6 M 56.5 M 60.7 M 41.6 M 23.2 M 57.6 M 51.1 M 37.6 M 21.3 M 22.4 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
60.7 M 21.3 M 42.8 M

Quarterly Operating Expenses Neoleukin Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
22.2 M 21.1 M - 15.2 M 12.6 M 15.1 M - 13.6 M 15.9 M 15.4 M - 15.5 M 15.1 M - - - 9.77 M 9.07 M - 59.5 M 428 K 2.66 M - 15.2 M 22.3 M 14.8 M - 12.1 M 14 M 8.52 M - 8.28 M 11.1 M 6.83 M - 4.92 M 4.79 M 6.04 M - 6.31 M 5.63 M 2.62 M - 3.42 M 1.62 M 997 K - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
59.5 M 428 K 11.9 M